Page 73 - Elsevier News Today

Deadline: 3-Jul-23 Elsevier is inviting applications from organizations to recognize and honor outstanding work towards a world powered by renewable

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently, the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater p...

Individuals who are immunocompromised are considered at higher risk for severe or longer disease with COVID-19. Understanding the systemic immune response is vital for research efforts to reduce its effects on multiple organs.

Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Conscious leadership implies self-awareness, empathy and a commitment to ethical behaviour

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year.

The overall ranking was topped by Western Sydney University followed by University of Manchester, UK and Queen’s University, Canada. Universiti Sains Malaysia bagged the fourth spot and University of Tasmania came fifth.

Researchers have used a mouse model of Alzheimer’s disease that replicates the silent period that occurs before symptoms become obvious.

Last month, the editorial team of NeuroImage resigned over the “unethical fees” charged by the journal’s publisher, Elsevier. Can scientists ditch the for-profit system?

About two-thirds of the risk for Alzheimer's disease (AD) is thought to arise from genetic influences, but about a third could be influenced by environment and lifestyle, opening the door for behavioral interventions that could delay or prevent pathophysiological changes that occur with AD.